Global

‡ In these countries please contact our distributor

OPSITE FLEXIGRID

Moisture Vapour Permeable Adhesive Film Dressing

Overview

Description

OPSITE FLEXIGRID Moisture Vapour Permeable Adhesive Film Dressing

OPSITE FLEXIGRID is a transparent, adhesive film, with a unique wound measurement grid. The film is moisture vapour permeable, conformable and extensible. It is clinically proven to provide moist wound healing for superficial wounds; it is also ideal for use as a secondary dressing and to help prevent pressure sores.


Features

  • Faster, safer, less painful wound healing
  • Superior film with acrylic adhesive
  • Waterproof film
  • Simple, effective application technique
  • Adaptable to awkward areas
  • Unique wound measurement grid


Benefits

Faster, safer, less painful wound healing
OPSITE FLEXIGRID has set the standard in moist wound healing by retaining the natural wound exudate which contains vital nutrients for growing cells, and white blood cells to prevent infection. OPSITE FLEXIGRID provides an environment for safer and less painful wound healing. The high moisture vapour permeability allows excess exudate to evaporate, preventing skin maceration.

Superior film with acrylic adhesive
The OPSITE FLEXIGRID film is highly extensible and conformable, which combined with its high moisture vapour permeability, means the dressing can be left in place for up to 14 days. This minimises interference at the wound site and reduces the amount of nursing time required.

Waterproof
OPSITE FLEXIGRID is impermeable to water and body fluids, protecting the skin underneath and allowing the patient to bathe without changing dressings. It also aids in the prevention of bacterial contamination.

Simple, effective application technique
OPSITE FLEXIGRID provides a simple and effective application system. The flexible carrier enables single handed application allowing the dressing to conform to the contours of the body. Its transparency enables accurate positioning over the wound site.

Adaptable to Awkward Areas
OPSITE FLEXIGRID has been designed to be adaptable for use on all areas of the body. It can be easily cut into strips or shapes for application to awkward areas such as heels, elbows and knees.

Unique Wound Management Grid
OPSITE FLEXIGRID incorporates a unique wound measurement device which allows simple but accurate assessments of the healing process to be made. After tracing the edges of the wound, the FLEXIGRID carrier can be removed and stored in the patient's notes.


Indications

OPSITE FLEXIGRID is indicated for:

  • Superficial wounds, such as shallow pressure sores, minor burns, cuts and abrasions.
  • Pressure sore prophylaxis and skin protection around stoma and under leg bags.
  • Use as a secondary dressing, for example over INTRASITE Gel Amorphous Hydrogel Dressing or ALLEVYN Cavity Wound Dressing.
  • To relieve pain in painful diabetic neuropathy.
  • To provide catheter fixation.


Contraindications / Precautions

OPSITE FLEXIGRID may be used on clinically infected wounds if the following precautions are followed:

  • The patient should be under medical/clinical supervision
  • The dressing should be changed daily
  • The patient should be receiving suitable systemic treatment.

Immuno-compromised patients and diabetic patients may require extra supervision. Care should be taken to avoid skin damage by repeated applications on patients with thin or fragile skin.

In common with all adhesive products, some cases of irritation and/or maceration of the skin surrounding the wound have been reported. It should be noted that inappropriate use or too frequent dressing changes, particularly in patients with fragile skin, can result in skin stripping.


Ordering information

Catalogue# Size Qty per Carton
4630 10cm x 12cm 50 dressings
4631 15cm x 20cm 10 dressings
4632 12cm x 25cm 20 dressings
4628 6cm x 7cm 100 dressing

Instructions for Use

Step 1

  • Wash hands before and after treating the wound
  • Gently clean the wound removing any debris and dry the surrounding skin. Ensure surrounding skin remains dry before application. Do not apply to heavily bleeding wounds.
  • Remove dressing from pouch.
  • Remove the backing paper marked 1, taking care not to touch the adhesive side.
  • Place the dressing over the wound using light pressure.


Step 2

Remove the backing paper marked 2, and smooth the dressing down. Press around the edges of the dressing.


Step 3

If required, record the wound size.


Step 4

Remove the green grid and keep in patients records.


Step 5

To remove the dressing, lift one corner and slowly stretch the film in a motion that is parallel to the skin. Handle and dispose of the used dressing with care.


Please see Overview tab for Contraindications/Precautions 

Clinical Support

Paper title: Fingertip injuries management with semi-occlusive dressing

Author: U Mennen and A Wiese

Reference: Journal of Hand Surgery (1993) 18: 416-422

Study abstract: We have developed a simple, cheap and efficient method of management of fingertip injury using a semi-occlusive dressing (OPSITE - Smith & Nephew). The fingertip is covered with the OPSITE once a week only. The dressing provides a temporary "skin", making the finger painless. This semi-occlusive "skin" allows the healing environment to reach an optimal milieu (eg. Ph, oxygen, tension, immunoagents) actively promoting granulation tissue formulation and epithelialisation. The result of 200 fingertip injuries treated with this method proves the development of a near normal pulp shape and useful epithelium within an average of 20 days.


Paper title: Application of OPSITE FLEXIGRID film: a new and effective treatment of painful diabetic neuropathy.

Author: A V M Foster, C Eaton, D O McConville, M E Edmonds

Reference: Diabetic Medicine (1994) 11: 768-772

Study abstract: The aim of the study was to assess the effect of application of OPSITE dressings on the pain and quality of life in 33 patients with chronic diabetic neuropathy. The effect of OPSITE was compared with no treatment. After a run-in period of 2 weeks, OPSITE was applied to one of the painful legs for 4 weeks. This was followed by another period of 4 weeks when OPSITE was switched to the opposite leg. Pain was assessed by visual analogue scale and the primary analysis variable was within patient difference in pain between OPSITE leg and no treatment leg as week 4 corrected for baseline. Secondary variables were paracetamol pill ingestion and the quality of life dimensions, sleep, mobility, contact, discomfort, appetite and mood. Changes in these variables from baseline to weeks 4 and 8 were analysed. There was a significantly greater reduction in pain in the OPSITE treated limbs than the control limbs (p < 0.001). OPSITE appeared to alleviate the pain associated with diabetic painful neuropathy and thus improved patient's quality of life.